CIBC Asset Management Inc boosted its stake in shares of Mylan N.V. (NASDAQ:MYL) by 4.8% during the second quarter, Holdings Channel reports. The fund owned 44,908 shares of the company’s stock after buying an additional 2,072 shares during the period. CIBC Asset Management Inc’s holdings in Mylan N.V. were worth $1,743,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in shares of Mylan N.V. by 3,447.5% in the first quarter. BlackRock Inc. now owns 38,822,643 shares of the company’s stock valued at $1,513,696,000 after buying an additional 37,728,274 shares during the last quarter. Pzena Investment Management LLC purchased a new stake in shares of Mylan N.V. during the first quarter valued at approximately $283,158,000. TIAA CREF Investment Management LLC boosted its stake in shares of Mylan N.V. by 187.3% in the first quarter. TIAA CREF Investment Management LLC now owns 4,315,668 shares of the company’s stock valued at $168,268,000 after buying an additional 2,813,653 shares during the last quarter. Morgan Stanley boosted its stake in shares of Mylan N.V. by 82.6% in the first quarter. Morgan Stanley now owns 4,174,499 shares of the company’s stock valued at $162,765,000 after buying an additional 1,888,905 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of Mylan N.V. by 2.6% in the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock valued at $1,808,088,000 after buying an additional 1,165,852 shares during the last quarter. 70.19% of the stock is owned by institutional investors and hedge funds.
Mylan N.V. (NASDAQ MYL) opened at 32.08 on Thursday. The stock’s 50 day moving average price is $37.74 and its 200-day moving average price is $39.09. The firm has a market capitalization of $17.19 billion, a price-to-earnings ratio of 32.05 and a beta of 1.27. Mylan N.V. has a one year low of $29.58 and a one year high of $49.42. Mylan N.V. also was the target of some unusual options trading on Monday. Stock traders purchased 9,410 call options on the stock. This represents an increase of 250% compared to the average daily volume of 2,688 call options.
Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. The firm had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $3 billion. Mylan N.V. had a net margin of 4.59% and a return on equity of 23.69%. The business’s revenue for the quarter was up 15.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.16 earnings per share. On average, equities research analysts expect that Mylan N.V. will post $5.12 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “CIBC Asset Management Inc Purchases 2,072 Shares of Mylan N.V. (MYL)” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/2797823/cibc-asset-management-inc-purchases-2072-shares-of-mylan-n-v-myl.html.
MYL has been the subject of several recent research reports. Deutsche Bank AG lowered their price target on Mylan N.V. from $52.00 to $51.00 and set a “buy” rating for the company in a research note on Tuesday, April 18th. Barclays PLC raised Mylan N.V. from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $47.00 to $50.00 in a research note on Monday, May 22nd. Royal Bank Of Canada reissued a “sector perform” rating and issued a $46.00 price target (down previously from $48.00) on shares of Mylan N.V. in a research note on Monday, April 17th. Zacks Investment Research cut Mylan N.V. from a “hold” rating to a “sell” rating in a research note on Monday, May 15th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating and set a $40.00 target price on shares of Mylan N.V. in a research report on Friday, April 14th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $49.40.
In related news, insider Anthony Mauro sold 10,000 shares of the business’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the completion of the sale, the insider now directly owns 140,653 shares in the company, valued at approximately $5,626,120. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Rajiv Malik sold 25,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.